Shortage reports
Actual shortage:
257 (7%)
Anticipated shortage:
3 (0%)
Avoided shortage:
11 (0%)
Resolved:
3300 (92%)
3571
Discontinuation Reports
To be discontinued:
24 (7%)
Discontinued:
342 (93%)
Reversed:
0 (0%)
366
143 (4%)
32 (11%)
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-LABETALOL TABLETS | 200MG | TABLET | Resolved | 2017-08-13 | 2021-01-11 | 19108 |
| APO-LAMIVUDINE | 300MG | TABLET | Resolved | 2017-07-11 | 2017-08-31 | 15271 |
| APO-LAMIVUDINE | 300MG | TABLET | Resolved | 2021-02-26 | 2021-06-28 | 134757 |
| APO-LAMIVUDINE | 150MG | TABLET | Resolved | 2017-03-11 | 2017-05-16 | 664 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2019-12-05 | 2020-02-25 | 100278 |
| APO-LAMIVUDINE HBV | 100MG | TABLET | Resolved | 2021-05-07 | 2021-06-28 | 138957 |
| APO-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG | TABLET | Resolved | 2023-01-13 | 2023-01-20 | 181110 |
| APO-LAMIVUDINE-ZIDOVUDINE | 300MG 150MG | TABLET | Resolved | 2017-12-06 | 2018-07-03 | 31907 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2022-08-26 | 2022-09-08 | 168044 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2020-05-08 | 2020-06-15 | 114288 |
| APO-LAMOTRIGINE | 100MG | TABLET | Resolved | 2020-02-05 | 2020-03-27 | 105345 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2023-09-01 | 2023-09-29 | 203545 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2021-02-12 | 2021-04-19 | 133988 |
| APO-LAMOTRIGINE | 25MG | TABLET | Resolved | 2019-09-04 | 2020-01-29 | 92978 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2023-06-16 | 2023-06-23 | 195075 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2019-01-03 | 2019-03-01 | 71130 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2019-08-07 | 2019-08-21 | 91081 |
| APO-LAMOTRIGINE | 100MG | TABLET TABLET | Resolved | 2020-12-11 | 2021-02-01 | 130045 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2023-08-12 | 2023-10-06 | 201693 |
| APO-LAMOTRIGINE | 150MG | TABLET | Resolved | 2020-12-18 | 2021-02-01 | 130404 |
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| APO-TIMOP | 0.5% | SOLUTION | Discontinued | 2019-01-03 | 2019-01-03 | 70894 |
| APO-TIMOP GEL | Discontinued | 2019-01-03 | 2019-01-03 | 71020 | ||
| APO-TIMOP OPH SOLN 0.25% | Discontinued | 2019-01-02 | 2019-01-02 | 70818 | ||
| APO-TOLTERODINE | 1MG | TABLET | Discontinued | 2018-09-08 | 2019-01-17 | 60822 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2019-06-12 | 60828 |
| APO-TOLTERODINE | 2MG | TABLET | Discontinued | 2018-09-08 | 2018-11-09 | 60825 |
| APO-TRAZODONE TABLETS 100MG | 100MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60831 |
| APO-TRAZODONE TABLETS 50MG | 50MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60834 |
| APO-VALACYCLOVIR | 500MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60840 |
| APO-VALGANCICLOVIR | 450MG | TABLET | Discontinued | 2018-09-08 | 2018-09-15 | 60843 |
| APO-VALPROIC ACID ORAL SOLUTION | 250MG | SOLUTION | Discontinued | 2023-09-26 | 2023-11-02 | 205310 |
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71029 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71032 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71035 | ||
| APO-VALSARTAN | Discontinued | 2019-01-03 | 2019-01-03 | 71038 | ||
| APO-VALSARTAN/HCTZ | 12.5MG 160MG | TABLET | Discontinued | 2019-01-03 | 2019-01-03 | 71054 |
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71044 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71048 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71051 | ||
| APO-VALSARTAN/HCTZ | Discontinued | 2019-01-03 | 2019-01-03 | 71057 |